[Lymphokine-activated killer (LAK) cells and interleukin-2 (IL-2) therapy that improved lymphadenopathy in a patient with B cell non-Hodgkin's lymphoma].

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples